HIV Resource Allocations using AEM

Similar documents
Ending the AIDS epidemic by 2030

HIV Modeling and Projection

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences

AIDS Funding Landscape in Asia and the Pacific

Leaving no one behind in Asia and the Pacific. Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream?

S P. HIV/AIDS Resource Allocation and the Goals Model. Steven Forsythe, PhD Futures Institute/INSP

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

Place matters: why cities are key to ending AIDS

Terms of Reference (TOR)

HIV/AIDS: Trends, Forecasts, Exploring HIV Policy and Program Alternative Predictions Using Deterministic Asian Epidemic Model

aids in asia and the pacific

Review of new NSPs in Asia and the Pacific Region

Improving Efficiency in Health Washington, D.C. 3 February 2016

Returns on investments of HIV prevention in Vietnam

Ministry of Health. National Center for HIV/AIDS, Dermatology and STD. Report of a Consensus Workshop

Integrated Behavioral Surveillance Survey among MSM in Bangkok

HIV in the Philippines: Still on the Rise. REGINA BERBA MD MSc Philippine General Hospital and The Medical City

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Technical Guidance Note for Global Fund HIV Proposals

Globalization & its Impact on Youth Health in Asia. Cai Cai Social Affairs Officer Health and Development Section Emerging Social Issues Division

The Goals Model as a Tool for Allocating HIV/AIDS Resources & Strategic Planning

Fifth National Conference on AIDS

Asia is large and diverse. HIV/AIDS: Regional and Thailand. The Asian HIV Epidemic. Praphan Phanuphak, M.D., Ph.D.

Scoring and Explanations UNAIDS RST and the regional HIV and AIDS Data Hub December 2011

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

Estimating resource needs and gaps for harm reduction in Asia

Preventing HIV Transmission in Intimate Partner Relationships

Workbook Method for estimating HIV prevalence in low level or concentrated epidemics

Progress, challenges and the way forward in ASEAN Member States

Improving access of migrant populations to HIV Services in the Caribbean 09/ /2013

NATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK

Strategic use of antiretroviral drugs to prevent HIV transmission

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Modelling and Simulation in Public Health

ART for prevention the task ahead

Optimizing Viet Nam s HIV Response: An Investment Case

HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur

HIV Prevention Prioritization & Implementation Brief: Anambra State

Strategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030

HIV Prevention Prioritization & Implementation Brief: Lagos State

HIV Modelling Consortium

Tracking the HIV/AIDS epidemic in

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

On the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda

UNGASS COUNTRY PROGRESS REPORT Republic of Armenia

How program science can help to create effec3ve and efficient HIV responses. Marelize Görgens The World Bank Global HIV/AIDS Program

BUDGET AND RESOURCE ALLOCATION MATRIX

Sexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam

CAMBODIA S FIFTH NATIONAL AIDS SPENDING ASSESSMENT (NASA),

ISHTAR - PROGRAMME REVIEW REPORT

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases

Addressing HIV prevention, care, and research priorities among MSM in Asia

STI and HIV Prevention and Care among Sex Workers

2 ESTIMATES AND PROJECTION OF HIV/AIDS IN INDONESIA

High Level Regional Consultation for Policy Makers to Enhance Leadership in Planning the National HIV & AIDS Response. HIV Prevention (PM1S4)

S P. Strategic Planning and Priority Setting. Barry Kistnasamy Nelson Mandela School of Medicine University of KwaZulu-Natal

HIV Prevention Prioritization & Implementation Brief: Kaduna State

Global AIDS Response Progress Report Myanmar. National AIDS Programme

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

APPLICANT REQUEST FOR MATCHING FUNDS. IMPORTANT: To complete this form, refer to the Instructions for Matching Funds Requests.

4th Asian Academic Society International Conference (AASIC) 2016 HEA-OR-095

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles

Policy Overview and Status of the AIDS Epidemic in Zambia

Contents. Acknowledgments Abbreviations and Acronyms 3

Strategic Planning for HIV/AIDS

BUSIA COUNTY REPORT ON THE HIV IMPLEMENTING PARTNERS ONLINE REPORTING SYSTEM (HIPORS) FOR THE FINANCIAL YEAR 2016/2017 FEBRUARY 2018.

HP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018

Rectal Microbicides: The Basics. Date, Location Your name, Your affiliation

Ending the AIDS Epidemic in Adolescents

HIV Prevention Prioritization & Implementation Brief: Gombe State

Nairobi City s Progress Towards Ending the HIV Epidemic. Dr. Carol Ngunu-Gituathi Deputy Director, Health Services, NAIROBI

High Impact HIV Prevention Services and Best Practices

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

Report of the First Meeting of the expert panel on health impact of Global fund investements

Combination prevention: Public health and human rights imperatives

Strategic Planning for HIV/AIDS

ASEAN Mental Health Task Force (AMT)

HIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE

Table of Contents. Evidence of Increasing HIV in Bangladesh 5. Epidemiological studies indicate HIV is increasing 5

Technical Guidance for Global Fund HIV Proposals

2004 Update. Georgia

Assessment of Impact of Harm Reduction Interventions among People Who Inject Drugs (PWID) in Dhaka City December 2014

Assessment of the allocation of HIV funding in Indonesia

National AIDS Spending Assessment Report Thai Working Group on National AIDS Spending Assessment Reporting date: July 12, 2012

Performance Management Plan Indicator Worksheet #1

M&E for Accountability & Global Progress Tracking

Projections for HIV/AIDS in Cambodia: The Cambodia Working Group on HIV/AIDS Projection

HIV Prevention Prioritization & Implementation Brief: Benue State

Towards universal access

Regional Capacity Development and Networking Program to Improve TADs Surveillance and Control

MANDERA COUNTY REPORT ON THE HIV IMPLEMENTING PARTNERS ONLINE REPORTING SYSTEM (HIPORS) FOR THE FINANCIAL YEAR 2016/2017 FEBRUARY 2018.

A Data Use Guide ESTIMATING THE UNIT COSTS OF HIV PREVENTION OF MOTHER-TO-CHILD TRANSMISSION SERVICES IN GHANA. May 2013

Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia

In collaboration with GLOBAL HEALTH SCIENCES, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. Training workshop

South Asia Multi Sector briefs on HIV/AIDS

Making the Money Work AIDS Strategy and Action Plan (ASAP)

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Transcription:

HIV Resource Allocations using AEM Tim Brown and Wiwat Peerapatanapokin Conference on Improving Efficiency in Health 3-4 February 2016 World Bank, Washington DC, USA 1

What is the AIDS Epidemic Model? AEM a behavioral process model Simulate transmission dynamics in concentrated epidemics Major transmission routes include: Vaginal sex (sex work, casual and marital) Anal sex (receptive and insertive) Needle sharing ART by sub-population Infectivity reductions on ART Coverage of ART in a given population Eligibility criteria NOTES: Pediatric transmission through Spectrum External infections can be added (blood, migrants, etc.) 2

What groups are included in AEM? FSW/ISW Client Low or no risk male TG MSM/MSW Low or no risk female IDU (M/F) Those that are important in concentrated epidemics As country needs dictate, add new groups 3

Internal male and transgender structure in AEM Male IDU Low risk network High risk network 15 year old males Heterosexual Non-Client Client Transgender Sex workers Casual partners Regular partners Same-sex male MSM2 MSM1 MSW Note: this movement Allows for turnover in The various groups Death 4

Internal female structure in AEM 15 year old females Female IDU Low risk network General Female Female Sex Worker FSW1 Non-injecting FSW1 ISW High risk network FSW2 Non-injecting FSW2 ISW Death 5

Each sub-group has uninfected & infected New infections through different routes calculated from behaviors Visit sex workers Uninfected Male Clients ( X 1 ) Extramarital sex Infected wives Infected Male Clients ( Y 1 ) Male Non-Clients IDUs MSMs MSWs Death 6

How are new infections calculated? N new_ Infections n contacts_ HIV p per_ contact New Infections = Size of risk group x Freq of contacts x HIV prevalence of partners (Chance to meet positive partners) x Fraction unprotected x Transmission probability x Adjustments for STI & circumcision x Adjustments for ART Total number of unprotected contacts with HIV positive partners 7

That determines the key inputs needed Biological data trends HIV prevalence, STI prevalence, circumcision in males Behavioral data trends - sexual Frequency of sexual activity, condom use with different partners, duration of sex work/clienthood (for turnover) Behavioral data trends injecting Frequency of injection, level of needle sharing, duration Sizes of key populations Entered as % of adult male or female population

Adjusting epidemic parameters The result: a model tuned to the country s epidemiological & behavioral situation 9

AEM Outputs Dashboard: customizable overview 10

AEM Outputs modes of transmission Details of new infections in a given year 11

AEM Outputs modes of transmission Details of infection sources 12

AEM Tools Suite: the Workbooks AEM Baseline: contains full inputs & results of a projection AEM Intervention: allows exploration of impacts & costs of alternative program scenarios to address the epidemic AEM Impact Analysis: compares scenarios on key policy outputs 13

AEM Optimization Tool add-on to AEM Tools Suite RunID FSW1 Cost FSW2 Cost IDU Cost MSM Cost MSW Cost TG Cost Total Cost 1 2,329,014 2,805,566 6,171,991 3,302,144 2,281,846 776,181 17,666,743 2 2,462,214 2,015,858 6,395,268 3,693,652 2,148,570 819,600 17,535,161 3 2,195,815 1,903,042 6,171,991 4,085,160 2,548,398 819,600 17,724,006 4 2,195,815 1,903,042 7,288,372 3,497,898 2,015,294 689,344 17,589,765 5 2,329,014 2,354,304 Cost 6,618,544 2,714,883 2,948,225 645,925 17,610,895 6 2,595,414 1,903,042 7,511,648 2,714,883 2,148,570 863,018 17,736,575 7 2,062,615 1,903,042 6,841,820 2,910,637 3,081,501 949,856 17,749,471 1,000 2,728,613 1,903,042 6,618,544 2,714,883 3,081,501 689,344 17,735,927 With similar total amount of funding, which scenario give us the best impact RunID FSW1 Cov FSW2 Cov IDU Cov MSM Cov MSW Cov TG Cov 1 33.0% 51.3% 68.1% 19.0% 38.6% 45.4% 2 34.9% 36.9% 70.6% 21.3% 36.3% 48.0% 3 31.1% 34.8% 68.1% 23.5% 43.1% 48.0% 4 31.1% 34.8% 80.5% 20.2% 34.1% 40.3% 5 33.0% 43.0% Coverage 73.1% 15.6% 49.9% 37.8% 6 36.8% 34.8% 82.9% 15.6% 36.3% 50.5% 7 29.3% 34.8% 75.5% 16.8% 52.1% 55.6% 1,000 38.7% 34.8% 73.1% 15.6% 52.1% 40.3% RunID New HIV 2017 New Death 2017 PLHIV 2017 1 1062 856 8922 2 1095 857 8955 3 1139 857 8999 4 1139 858 8998 Impact 5 1077 856 8938 6 1003 856 8863 7 1135 857 8996 1,000 983 855 8843

AEM has been applied extensively to modeling epidemics in Asia and in Peru & Ukraine 15

AEM has been applied in many analyses for improving efficiency in resource allocation Cost-effectiveness analysis Investment case analysis Optimization analysis (Allocative Efficiency) Strategic ART use analysis Combined treatment & prevention impact Exploring any combination of coverage, costs and program effectiveness Countries applied AEM for Input for strategic planning (NSPs) Input for GF NFM Concept Note Tools for advocacy, e.g., resource mobilization

AEM Process (1) First, produce historical AEM baseline Size estimates Risk behaviors HIV prevalence Costs Coverage Data collation and review, analysis, calibration and trend extraction FSW, clients, MSM, PWID, Gen pop M&F Model is tuned to country context AEM Calculation Engine

This provides a clear picture of where epidemic has been, where it is & where it is going Nepal

AEM Process (2) Second, calculate program effects on epidemic 19

AEM Process (3) Third, compare program alternatives, select most effective both with existing resources and with even more Indonesia different geographic Philippines reversing the prioritizations epidemic

AEM analysis done as national in-country process Normally a series of 3 or more workshops National program usually leads Extensive engagement of stakeholders Epidemiologists, program managers, behavioral scientists, national planners, policy makers, communities, international partners, donors Assist in finding data & validating models Choose and assess feasibility of scenarios Jointly plan for dissemination & advocacy Informs NSP, concept note development

Process involves extensive scenario analysis Many scenarios are run to assess impact of alternative responses Vietnamese scenarios explored

Process raises awareness of critical issues Philippines low coverage Vietnam shrinking resources

Process highlights costs of effective responses Indonesia living with HIV Resource needs

Process highlights return on investment Keep Focusing prevention Expanding ART in Thailand leading to Treat All policy with highly cost-benefit

Lesson learned: in-country engagement has many benefits process as important as product Brings more data and program information into the light Maximize data use, people who share have more ownership Lets the data talk to people who haven t seen it before Raises general awareness of strengths and weaknesses in: Data systems (e.g. data gaps) Capacity to respond Responses themselves Builds a common understanding of the epidemic and what is most important to containing it Builds ownership of the outputs and strengthens advocacy process

Lesson learned: process keeps audience in mind Write the analysis results for a general audience Focus on key messages Keep technical details to appendices or other Additional policy briefs and advocacy material have proven helpful Philippines and Thailand briefs prepared for policy advocacy

Example of AEM analysis: Thailand

Example of AEM analysis: Viet Nam Viet Nam Investment Case: Funding vs New infection Baseline CD4.50+T asp

Viet Nam Investment Case

Example of AEM analysis: Philippines Philippines Investment Options Towards Ending AIDS : impact on annual new infections up to 2030 Ending AIDS reduces new HIV infections to less than 500 a year by 2020. At that level, HIV will no longer be a major public health threat.

Example of AEM analysis: Indonesia Indonesia Optimization Analysis

Example of AEM analysis: Bangladesh Bangladesh Investment Case

Example of AEM analysis: Nepal Nepal Investment Case 34

Example of AEM analysis: Cambodia Cambodia Policy Analysis 35

Example of AEM analysis: Myanmar Myanmar Fast tract for Ending AIDS: Number of New Infections 36

Total DALY saved Thousands Example of AEM analysis: Malaysia Malaysia Investment impact : Return of investment Total investment for Ending AIDS : USD 429 million (RM 1.6 billion) in 7 years - Prevention : USD 78 million (18%) - ARV: USD 351 million (82%) Save 644,000 Life years (DALY) equivalent of USD 6.8 billion (RM 25 billion) GDP Invest 1 USD Get 16 USD Saving USD 6.4 billion! Save lives + Save money 700 600 500 400 300 200 100 0 Total investment and DALY saved, 2015-2021 Scale-up prevention only 504k Scale-up HR (PWID)+treatment CD4<350 431k Scale-up HR (PWID)+treatment CD4<500 474k Ending AIDS 644k Scaleup treatme nt only 296k Business as usual 0 100 200 300 400 500 Total investment (USD) Millions

Conclusions The AEM model forms an organizing framework for linking epi & behavior to programs and their impacts Applied in a collaborative AEM process it: Engages key stakeholders Educates people about their epidemic & response Provides direct estimates of comparative program impacts Building capacity to apply AEM in-country builds capacity for informed program guidance and impact assessment